Floatz logo

Nicotine

Constipation, Impaction, and Bowel Obstruction

Mayo ClinicSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Constipation, Impaction, and Bowel Obstruction cohort.

Asset / SponsorPhaseRating
Rocuronium
Stony Brook University
Phase 4BB
FENTANYL
University of Illinois College of Medicine at Peoria
Phase 4BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
University of Illinois College of Medicine at Peoria
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
University of Illinois College of Medicine at Peoria
Phase 4BB
Dilaudid
University of Illinois College of Medicine at Peoria
Phase 4BB

View all 19 →

Same molecule, other indications

Nicotine is also rated in:

nicotine dependenceDormant
A
Indicative ·
83 / 100
View asset →
nicotine dependenceDormant
BBB
Indicative ·
73 / 100
View asset →
cognitive disorderDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →